Compound combinations targeting longevity: Challenges and perspectives

Area of Science:

• Gerontology and longevity research.
• Pharmacology and drug development.
• Biomedical science and chronic disease prevention.

Background:

• Aging is a major global concern, increasing chronic disease risk and reducing healthspan.
• Current anti-aging therapies often target only a limited number of aging-related mechanisms.
• Combination therapy presents a biologically rational approach to enhance anti-aging effects.

Purpose of the Study:

• To review different types of compound combinations for modulating lifespan.
• To discuss evidence supporting combination interventions for life extension.
• To highlight challenges and future directions in combination anti-aging drug therapy.

Main Methods:

• Literature review of existing studies on anti-aging compound combinations.
• Analysis of evidence for lifespan modulation and healthspan extension.
• Synthesis of current challenges and future prospects in the field.

Main Results:

• Various combination strategies exist to target multiple aging pathways.
• Evidence suggests combinations can enhance geroprotective effects compared to single agents.
• The review identifies key challenges in developing and implementing combination therapies.

Conclusions:

• Combination anti-aging drug therapy is a promising strategy to improve healthspan and combat aging.
• Further research is needed to overcome challenges and optimize combination approaches.
• Developing effective combination therapies could significantly impact public health and longevity.